Wellington Management Group
DSGN icon

Wellington Management Group’s Design Therapeutics DSGN Stock Holding History

Wellington Management Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
+19,400
New +$242K ﹤0.01% 1869
2025
Q2 		– Sell
-141,519
Closed -$546K – 1969
2025
Q1 		$546K Buy
+141,519
New +$675K ﹤0.01% 1810
2024
Q3 		– Sell
-256,627
Closed -$860K – 1939
2024
Q2 		$860K Buy
256,627
+42,317
+20% +$165K ﹤0.01% 1705
2024
Q1 		$864K Buy
+214,310
New +$572K ﹤0.01% 1716
2023
Q3 		– Sell
-502,375
Closed -$3.16M – 1828
2023
Q2 		$3.16M Sell
502,375
-47,957
-9% -$293K ﹤0.01% 1381
2023
Q1 		$3.18M Sell
550,332
-192,408
-26% -$1.44M ﹤0.01% 1393
2022
Q4 		$7.62M Sell
742,740
-206,033
-22% -$2.79M ﹤0.01% 1158
2022
Q3 		$15.9M Sell
948,773
-109,876
-10% -$2.19M ﹤0.01% 981
2022
Q2 		$14.8M Buy
1,058,649
+59,476
+6% +$803K ﹤0.01% 1022
2022
Q1 		$16.1M Buy
999,173
+143,635
+17% +$2.2M ﹤0.01% 1070
2021
Q4 		$18.3M Sell
855,538
-100,050
-10% -$1.72M ﹤0.01% 1103
2021
Q3 		$14M Buy
955,588
+16,226
+2% +$270K ﹤0.01% 1173
2021
Q2 		$18.5M Sell
939,362
-202,623
-18% -$5.11M ﹤0.01% 1111
2021
Q1 		$33.5M Buy
+1,141,985
New +$38.5M 0.01% 927

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's DSGN Position: Q2 2026 in Review

Wellington Management Group opened a new position in Design Therapeutics (DSGN) in Q2 2026: 19,400 shares worth $281K. The stake represents ﹤0.01% of the portfolio and ranks #1869 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in DSGN as recently as Q1 2025.

Wellington Management Group first reported a position in DSGN in Q1 2021 and has held it in 14 quarters since. The position peaked at $33.5M in Q1 2021. 137 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Wellington Management Group held 19,400 shares of Design Therapeutics worth $281K as of Q2 2026.
  • Design Therapeutics was a new Wellington Management Group position in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1869 holding.
  • Wellington Management Group first reported a position in Design Therapeutics in Q1 2021 and has held it in 14 quarters since.
  • Wellington Management Group's Design Therapeutics position peaked at $33.5M in Q1 2021.
  • 137 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.